Chemomab Therapeutics Ltd. CMMB
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -28.60% | -27.34% | -26.42% | -33.47% | |
| Total Receivables | 197.00% | -25.86% | 68.35% | 43.95% | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -- | 99.58% | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | 100.00% | 86.67% | |
| Total Current Assets | -6.19% | -16.30% | -21.11% | -28.86% | |
|
|
|||||
| Total Current Assets | -6.19% | -16.30% | -21.11% | -28.86% | |
| Net Property, Plant & Equipment | -27.19% | -67.35% | -64.83% | -23.63% | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -58.72% | -45.19% | -36.86% | -33.91% | |
| Total Assets | -8.01% | -18.58% | -23.48% | -28.82% | |
|
|
|||||
| Total Accounts Payable | -32.01% | -27.18% | -66.04% | -7.02% | |
| Total Accrued Expenses | 23.19% | -59.25% | -65.91% | -56.29% | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | 2.73% | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 8.60% | -54.07% | -66.81% | -48.91% | |
|
|
|||||
| Total Current Liabilities | 8.60% | -54.07% | -66.81% | -48.91% | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -36.07% | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 8.60% | -56.87% | -68.63% | -48.14% | |
|
|
|||||
| Common Stock & APIC | 5.56% | 6.71% | 10.87% | 9.88% | |
| Retained Earnings | -6.99% | -8.77% | -12.30% | -14.48% | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | -10.45% | -8.89% | -2.86% | -22.04% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -10.45% | -8.89% | -2.86% | -22.04% | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -10.45% | -8.89% | -2.86% | -22.04% | |
|
|
|||||